Alert # 1:
SHINGRIX SUPPLY ALERT: Beginning December 9, 2019, only single-dose packages of SHINGRIX (58160-819-12) will be available on GSKDirect.com. Your maximum order will continue to be 10 doses of SHINGRIX per order, however you will now have the flexibility to order a minimum of 5 doses. The ten-dose package (58160-823-11) option will be disabled from ordering on www.GSKDirect.com until further notice. For more information please click here.
Alert # 2:
Due to unprecedented levels of demand for SHINGRIX, providers should anticipate ordering limits, backorders and shipping delays for SHINGRIX. GSK is currently working to make more doses available in the near term for the US market in order to meet the demand for this vaccine.
Alert # 3:
Due to Merck’s continued hepatitis B supply shortage lasting throughout 2019 and into 2020, GSK has communicated to the CDC that we will be able to cover this shortage using a combination of ENGERIX-B, GSK’s monovalent hepatitis B vaccine, and PEDIARIX (DTaP-Hep B-IPV) (for doses other than the birth dose).
